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LETTERS TO THE EDITOR
Batista’s Operation: What Have We Learned?
The recent editorial comment by Dr. Ratcliffe (1) on two articles
(2,3) concerning partial left ventriculectomy (PLV) raises some
issues that we would like to clarify. In his comment Dr. Ratcliffe
questions the accuracy of the conductance catheter method based
upon a comparison between our measurements obtained by ther-
modilution and conductance catheter. The illustration presented
(Fig. 1 of his comment) appears to demonstrate poor agreement
between the two methods. Unfortunately, this is due to a misin-
terpretation of the data presented in Table 2 in our article (3).
Figure 1 in Dr. Ratcliffe’s comment shows a comparison between
stroke volume (SV) measured by thermodilution and by conduc-
tance catheter, the latter using the difference between left ventric-
ular (LV) end-diastolic volume (EDV) and end-systolic volume
(ESV). However, whereas thermodilution measures effective for-
ward flow, the difference between EDV and ESV also includes
both mitral and aortic regurgitant flows. Therefore, the difference
between the measurements by the two methods, as plotted on the
y-axis of Figure 1, in fact represents the sum of aortic and mitral
regurgitant stroke volumes. Thus, the finding that this difference is
substantial (mean difference 18 ml) merely reflects the presence of
substantial mitral and aortic regurgitation in this patient group.
In retrospect we performed the same analysis as Dr. Ratcliffe,
and we subsequently separately analyzed data before and after
PLV. Before PLV, mean regurgitant SV was 27 6 19 ml, whereas
post-PLV it was reduced to 12 6 10 ml, consistent with the aortic
valve surgery performed in one patient and mitral valve surgery
performed in seven patients. Furthermore, the conductance vol-
umes as presented in Table 2 in our article (3) are, in fact,
calibrated by matching thermodilution-derived SV with effective
conductance SV (p. 2106 of our article). The latter is obtained as
the difference between conductance volumes at the times of
dP/dtMIN and dP/dtMAX, which largely eliminates the contribu-
tion of regurgitant flows. As mentioned in our study, this calibra-
tion on the basis of thermodilution was performed in each patient
at each condition. Therefore, a comparison between thermodilu-
tion and conductance-derived SV, as attempted in the editorial
comment, is not meaningful.
A striking observation of the present and other PLV studies is
the unchanged SV after the procedure in these patients. One of our
main findings, unfortunately not discussed in the editorial com-
ment, was the improvement in mechanical LV synchrony. Me-
chanical nonuniformity as demonstrated in these patients is an
important factor in cardiac dysfunction in heart failure patients.
Our results indicate, as demonstrated by the highly significant
positive correlation between cardiac index and LV synchrony
index, that PLV produces its beneficial effects partly by improving
mechanical synchrony. The increase in LV synchrony immediately
after PLV may lead to an improved mechanical efficiency of
ventricular ejection, compensating an expected decrease in SV.
In our view the occurrence of the marked change in LV
segmental asynchrony precludes realistic estimation of the effects
of PLV on the Starling relationship (SV vs. sarcomere length),
because mean sarcomere lengths before and after PLV are un-
known and cannot simply be derived from LV end-diastolic
pressure (EDP) or LV EDV due to the change in LV segmental
asynchrony. Moreover, the excision of LV mass and concomitant
change of LV intracavitary volume also preclude estimation of
sarcomere length change from both EDV and EDP.
Finally, it would be interesting to implement LV segmental
volume asynchrony in models such as used by Dickstein et al. (4)
and by Ratcliffe et al. (5). In general, we agree that numerical
models may provide data that are difficult or impossible to obtain
in in vivo studies. However, studies such as described by Starling
et al. (2) and by us (3) will always be required initially to feed the
numerical models with input data and ultimately to check whether
the results produced by these models are meaningful and consistent
with data obtained in the intact heart.
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A Randomized Trial of
Multivessel Stent Versus Coronary Bypass
In a recent Journal article, Rodriguez et al. (1) reported that the
rates of death and myocardial infarction during long-term
follow-up were lower in patients undergoing percutaneous trans-
luminal coronary revascularization (PTCR) than in patients un-
dergoing coronary artery bypass graft (CABG) surgery. This
conclusion requires careful scrutiny owing to possible under-
reporting of major events.
The study was designed with a composite primary end point
that included death, myocardial infarction, cerebrovascular acci-
dent and myocardial re-revascularization. Presumably, once a
patient experienced a primary end point event, that patient would
be withdrawn from further analysis. A patient who underwent a
second revascularization procedure and subsequently died would
not be reported as a death, for example. In the Rodriguez et al.
study, patients randomized to PTCR were more likely to have a
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second revascularization procedure than were those assigned to
CABG. Subsequent major events occuring in such patients would
not be reported. This would bias the mortality and myocardial
infarction rates in favor of PTCR.
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REPLY
We disagree with the comments made by Dr. F. James Brennan
that major events were underreported in our recent Journal article
(1). Although we used a composite end point that included death,
myocardial infarction, cerebrovascular accident and myocardial
revascularization, we also separately reported mortality, myocardial
infarction, repeat revascularization procedures and stroke (1).
For example, as outlined in the Results section, there were
thirteen 30-day deaths in the coronary artery bypass graft (CABG)
group and two deaths in the percutaneous transluminal coronary
revascularization (PTCR) group. After one month, five patients
died in the PTCR group and four in the CABG group. These
deaths are reflected in the Kaplan-Meier survival curves shown in
our Figure 2, demonstrating a better survival in the PTCR group
compared with CABG group (96.9% vs. 92.5%, respectively, p ,
0.017).
We employed the Kaplan-Meier method to estimate length of
survival, freedom from myocardial infarction, freedom from repeat
revascularization procedures and freedom from combined events
for patients treated with CABG and with PTCR (see our Figs.
2–4). Comparison between groups was performed using the
log-rank test. The Kaplan-Meier method is an appropriate means
of estimating survival and other major events in our study. Because
each of the events (mortality, myocardial infarction and repeat
revascularization procedures) was analyzed separately using the
Kaplan-Meier method, there was no under-reporting of major
events. Although a given patient may have experienced a nonfatal
primary end point, he or she was not excluded from the analysis of
the other events. The Kaplan-Meier method allows the estimation
of survival time of each patient who dies and provides exact survival
proportions; this is because it uses exact survival times. The same
principle was applied in the calculation of freedom from myocar-
dial infarction and freedom from repeat revascularization proce-
dures.
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Lean Tissue Adjusted Peak Oxygen
Consumption in Congestive Heart Failure
Osman et al. (1) recently reported data on the prognosis of 225
patients with heart failure. In their analysis they sought to test the
hypothesis that peak oxygen uptake gains prognostic power when
expressed per lean body mass. Taking the present and other
available data (2,3), we entirely agree that this may in fact be
possible. However, we also see a number of problems in the present
article with regard to exercise testing, the patient group itself and
its very low event rate, as well as the statistical analysis. Therefore,
we cannot consider their article to offer proof of its conclusion.
The mean peak oxygen uptake (VO2) of their population of heart
failure patients was 16 ml/kg/min. The mean anaerobic threshold
was 12.7 ml/kg/min, and the peak heart rate was only 126
beats/min. Although mentioned in their Methods section, the
investigators’ data for respiratory exchange ratio at peak exercise, a
marker of metabolic stress, are not given anywhere in their report.
The investigators chose to present event rates based on 14 deaths
and 15 urgent transplants. In other words, the total mortality rate
in this population was about 7% during 19 months of follow-up.
This study group appears on average to have been in mild heart
failure. This low mortality rate is surprising given the mean peak
VO2 of 16 ml/kg/min. Even if urgent transplant is included in the
end point, the 12-month event rate in patients with peak VO2 #14
ml/kg/min is still only about 15%, which seems very low. Using the
same cutoff, Mancini et al. (4) reported a mortality rate of 30% to
53% in 12 months. Taken together, this raises concern about the
validity of their exercise tests, suggesting that an adequate VO2 may
not have been reached.
Whichever way one examines the data, the total event number
of 29 appears too small to perform extensive statistical analyses.
The main statistical analysis in the Osman et al. (1) article is
concerned with comparing peak VO2/weight versus peak VO2/lean
weight as a continuous or dichotomous variable, respectively.
Unfortunately, the receiver-operator curves (ROCs) for the two
continuous variables are not presented, and the arguments are
based on somewhat different chi-square (20.53 vs. 17.17) and p
values (0.0001 vs. 0.0007). No statistical comparison for the two
continuous variables is provided. Also, the comparison of the two
cutoffs appears difficult to interpret.
First, the data in their Table 2 (1) do not specify the follow-up
period to which they relate. Second, calculation of the ROC is
reserved for variables with many different levels. In their Table 2,
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